It was a long process (but not abmormal), not the 1-2 days
It was a long process (but not abmormal), not the 1-2 days people keep posting about on here.
June 11: Reached Complete Enrollment w/Primary Endpoint 14 after
June 25: Start of Unblinding "SHOULD HAVE" Occurred (but no update provided by Cytodyn)
July 13 (~18 past the point of process to unblind data): CytoDyn is planning to lock and unblind the Phase 2 COVID-19 trial data later this week.
*so basically it took 3 weeks after the final patient reached completion of P.E. before announcing unblinding
July 21 (~26 past the last pt reaching 14 day P.E., and ~8 past The July 13 PR stating unblinding to occur that week): Cytodyn Announces ONLY SAE Data, nothing else - "Evaluation of safety data indicates the following"
August 11 (~47 past the last pt reaching 14 day P.E. and 21 days past release of only SAE data): CytoDyn Announces Clinically Significant Top-line Results
In short, Cytodyn must accomplish the following for our upcoming CD12 Release:
1) after last pt has gone 28 days, the Principal Investigator at each of our trial sites has to verify and validate the data.
2) then the P.I. must Sign Off on data then Lock Data. Each trial site may take varying amounts of time to complete based upon any number of factors affecting workload.
3) I don't believe the trial sites can send the data to Cytodyn/Amarex though until ALL trial sites have signed off and locked data (but would need to verify that statement for accuracy)
4) Unblinding will occur after ALL Sites have signed, locked, and transmitted data
5) Amarex will begin Analysis of Data. For CD12, this will not necessarily be as simple as counting number of deaths, but rather Analysis needs to be performed on cause of death as well.
6) I have no clue how long process will take with CD12 vs CD10. It could easily follow the same timeframe for the time it took to sign, lock, and unblind data, which was 26 days past last pt reaching P.E., but I also wouldn't place a bet on that. My guess is the process will be much faster this time around. How fast I'm not sure. Can't imagine we will wait 26 days again for SAE events, but I'm hopeful for 7 days. Exciting times are in store.
**Anyone that has more specific steps for the process, please share. Thanks!
21
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...
Continue Reading
Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...
Continue Reading
Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...
Continue Reading
A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...
Continue Reading
NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...
Continue Reading
Top 5 Most Recently Viewed Articles
Is Novagold's Merger Really Beneficial? Something smells fishy in the world of precious metals, and no, it’s not the gleam of gold we’re talking about. The latest buzz is about Novagold Resources Inc. (NYSE American: NG) and their merger with Donlin Gold LLC. You know the routine: two companies make googly eyes at each other, and before you know it, there’s a merger...
Continue Reading
Overview of the Global Hemp-Based Food Market The Global Hemp-Based Food Market is on track for significant growth, expected to rise from USD 1.42 billion to USD 4.87 billion. This represents a strong Compound Annual Growth Rate (CAGR) of 13.12% over the forecast period. The surge in this market can be attributed to increasing health awareness and a growing preference for...
Continue Reading
Anticipating Carnival's Earnings Forecast Carnival (NYSE: CCL) is gearing up to unveil its quarterly earnings report soon. Investors are keenly observing the upcoming announcement, which is expected to significantly impact market sentiment. Analysts foresee an earnings per share (EPS) of $0.25, a figure that has generated considerable discussion among stakeholders....
Continue Reading
ModuleMD Revolutionizes Allergy Care at AAAAI 2025 Event ModuleMD made a significant impact at the recent AAAAI event, showcasing 25 years of dedication to allergy practice solutions. As a leader in this industry, their presentation was not just a display; it was an experience that included innovative product launches, interactive demos, and discussions that captivated...
Continue Reading
Billy Markus, a.k.a. Shibetoshi Nakomoto, has struck back at the endless chatter linking him to Bitcoin—like, c’mon people! This dude is solely about Dogecoin. In a flurry of tongue-in-cheek tweets, he laid bare his status: no ties to Bitcoin or any new crypto projects since his last ride with Doge in 2014. His mantra? If it ain't Dogecoin or his old side gig 'Bells,'...
Continue Reading